ESR1 and breast cancer: Under the hypothesis of differential risk associations according to breast cancer subtypes, we combined data from 31 nested and population-based case-control studies to investigate the association between OC and MHT use and breast cancer and to test heterogeneity primarily by intrinsic-like subtype and secondarily by ER subtype.